• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SISTEMAS MEDICOS ALARIS, S.A. DE C.V. BD ALARIS¿ LVP 20D 2SS CV; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SISTEMAS MEDICOS ALARIS, S.A. DE C.V. BD ALARIS¿ LVP 20D 2SS CV; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 2420-0007
Device Problem Excess Flow or Over-Infusion (1311)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/14/2022
Event Type  malfunction  
Event Description
It was reported that 1 bd alaris¿ lvp 20d 2ss cv had check valve malfunction issues.The following information was provided by the initial reporter : the customer reported that the primary bag mounted on the pole and lowered the secondary bag down below the primary (the entire infusion kit set clamped downstream of the junction between the two kits) to re-fill the secondary.Then raised the secondary bag back above the primary bag (mounted correctly on the pole with an 8â¿쳌 head), we observed rapid backflow from the secondary kit into the primary.This test was repeated multiple times to the same result.This clearly shows that the bcv was malfunctioning and was the root cause of this incident.In the process of this testing, the bcv began to function correctly and is currently preventing backflow.Event date: (b)(6) 2022.
 
Manufacturer Narrative
Initial reporter second phone# : (b)(6).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that 1 bd alaris¿ lvp 20d 2ss cv had check valve malfunction issues.The following information was provided by the initial reporter : the customer reported that the primary bag mounted on the pole and lowered the secondary bag down below the primary (the entire infusion kit set clamped downstream of the junction between the two kits) to re-fill the secondary.Then raised the secondary bag back above the primary bag (mounted correctly on the pole with an 8â¿쳌 head), we observed rapid backflow from the secondary kit into the primary.This test was repeated multiple times to the same result.This clearly shows that the bcv was malfunctioning and was the root cause of this incident.In the process of this testing, the bcv began to function correctly and is currently preventing backflow.Event date: june 14, 2022.
 
Manufacturer Narrative
The following fields were updated due to additional information: d10: device available for eval yes, d10: returned to manufacturer on: 01-jul-2022.H6: investigation summary one sample was received for quality investigation.The customer complaint of check valve failure was not verified by investigation.Evaluation was conducted by simulating an infusion using the sample provided.The primary infusion set was primed with saline solution and the secondary set, that was supplied with the sample, was primed using a solution with blue dye to determine if the check valve is allowing for backflow into the primary infusion bag.The primary infusion set was set to pump at a rate of 200ml/hr.The secondary infusion bag, with dyed water, was placed 9 inches above the primary infusion bag and the infusion was monitored to see if the dyed liquid would travel back past the check valve into the primary infusion bag.There was no backflow past the check valve observed.The secondary infusion bag height in comparison to the primary bag height was adjusted to try and simulate the reported failure.There were no instances, at different height levels, where they dyed liquid traveled backwards past the primary infusion set check valve.No other issues were noted during the investigation.A device history record review for model 2420-0007 lot number 22036099 was performed.The search showed that a total of (b)(4) units in 1 lot number was built on 17mar2022.There were no quality notifications issued for the failure mode reported by the customer during the production build of this set.A root cause could not be established because the reported failure could not be replicated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD ALARIS¿ LVP 20D 2SS CV
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
SISTEMAS MEDICOS ALARIS, S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer (Section G)
SISTEMAS MEDICOS ALARIS, S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key15032627
MDR Text Key304540250
Report Number9616066-2022-00889
Device Sequence Number1
Product Code FPA
UDI-Device Identifier07613203021012
UDI-Public07613203021012
Combination Product (y/n)Y
Reporter Country CodeCA
PMA/PMN Number
K944320
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/15/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number2420-0007
Device Lot Number22036099
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/06/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/17/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-